Edwards Lifesciences Aktie
69,94
EUR
+2,21
EUR
+3,26
%
82,49
USD
+2,69
USD
+3,37
%
Werbung
Edwards Lifesciences Aktie Analyse
| 16.10.18 | Edwards Lifesciences Underweight | Barclays Capital | |
| 05.12.12 | Edwards Lifesciences sell | UBS AG | |
| 15.11.12 | Edwards Lifesciences sell | UBS AG | |
| 12.04.10 | Edwards Lifesciences verkaufen | Wedbush Morgan Securities Inc. | |
| 28.07.09 | Edwards Lifesciences underperform | Wedbush Morgan Securities Inc. | |
| 09.03.07 | Edwards Lifesciences underweight | Morgan Stanley | |
| 06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
| 06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
|
Werbung
|
|||
| 14.06.05 | Edwards Lifesciences Underperform | First Albany | |
Werbung
Werbung